Analysis Examines Effects News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Analysis Examines Effects. Real-time updates on events, politics, business and more.

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023

May 30, 2023

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new research examining the use of Otezla® (apremilast) in psoriatic arthritis, including the Phase 4 MOSAIC...

Puerto Rico United States Ponda Motsepe Ditshego Michael Strapazon Jessica Akopyan University Of Copenhagen

Source: prnewswire.com

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023

May 30, 2023

MOSAIC Study is First to use MRI to Assess Inflammation in Peripheral Joints and Entheses in Psoriatic Arthritis Patients Exploratory Analysis Examines Effects of Otezla on Cardiometabolic... | June 7, 2023

Puerto Rico United States Ponda Motsepe Ditshego Jessica Akopyan Michael Strapazon Arthritis Research

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Analysis Examines Effects News Today

AMGEN PRESENTS NEW RESEARCH ON OTEZLA&#xAE; (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023

AMGEN PRESENTS NEW RESEARCH ON OTEZLA&#xAE; (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023

Explore More Categories

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023